Fair value (multi-method)
Four independent methods triangulate what AEHR is worth. The headline is the Forward-DCF intrinsic value at a normalized growth rate; the margin of safety compares it to the current price.
Estimated fair value (Forward DCF)
—
Method range
$1.47 – $62.00
median $5.69
Valuation methods
Each method’s implied fair value per share and its upside versus the current price. Missing methods (no analyst coverage, negative earnings, etc.) are shown as “—”.
| Method | Fair value | Upside vs price |
|---|---|---|
| Forward DCF | — | — |
| Exit multiple | $5.69 | -94.75% |
| Analyst target | $62.00 | -42.84% |
| Graham number | $1.47 | -98.65% |
- Forward DCF—
- Exit multiple$5.69
- Analyst target$62.00
- Graham number$1.47
Stock price
$108.47
EPS (TTM)
N/A
5Y EPS CAGR
95.6%
Fair value @ hist. growth
—
This analysis is for informational purposes only and is not financial advice. Scenario prices and DCF-style figures depend on your assumptions and data from public filings and estimates. They are not forecasts of future returns.
Reverse DCF did not solve for the current inputs — adjust discount rate, terminal growth, or horizon below.
Model inputs
Move sliders to test how the reverse DCF reacts. Historical-growth markers show where the company has actually grown over the last cycle.
Historical multiples
Each bar is the trailing five-year range (low left, high right). Filled portion runs from low to today; the dot marks today; the small tick marks the five-year median. Low, median, and high are listed under each bar.
PEG
9.86
Demanding vs growth
Net cash
$14M
Total debt − cash
Beta
3.18
Vs market benchmark
Annual diluted EPS
Per-share earnings by fiscal year — last 5 years anchor the CAGR reference above.
Frequently asked questions
Aehr Test Systems (AEHR) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation